Prostaglandin E2 induces inhibin alpha- and beta A-subunit mRNA and secretion of dimeric inhibin A in cultured human granulosa-luteal cells.
Prostaglandins (PG) E2 and F2 alpha are produced by the human corpus luteum in significant amounts and they are known to exert local luteotrophic and luteolytic effects respectively. The present study determined how PGE2 and PGF2 alpha are involved in the regulation of inhibin A, a granulosa cell-derived glycoprotein hormone that has an endocrine inhibitory effect on hypophyseal gonadotrophin production and a local stimulatory action on thecal cell androgen secretion. The effects of PGE2 and PGF2 alpha on inhibin alpha- and beta A-subunit mRNAs levels and on the secretion of dimeric inhibin A were studied in cultures of human granulosa-luteal cells obtained from patients undergoing an in-vitro fertilization programme. We found that PGE2 induced mRNA of inhibin alpha- and beta A-subunits in a time- and concentration dependent manner, whereas PGF2 alpha had no clear effect. In contrast to the rapidly and transiently induced beta A-subunit mRNA, alpha-subunit mRNA accumulation was stimulated with slower kinetics by PGE2 in a protein synthesis-dependent manner; this was also observed for the mRNA of the cytochrome P450scc enzyme. In the medium of cells cultured for 24 h with PGE2 (1 x 10(-6) M), 1.3-1.6-fold increase (P < 0.05) above basal values in secreted dimeric inhibin A was observed. The results suggest that PGE2 is an important inducer of inhibin A production in granulosa cells and that a local action of PGE2 may partially explain the increase in circulating inhibin A observed during the midluteal phase of the human menstrual cycle.
Erämaa
M
M
Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Finland.
Ritvos
O
O
D002478:Cells, Cultured; D019281:Dimerization; D015237:Dinoprost / Q000494:pharmacology; D015232:Dinoprostone / Q000494:pharmacology*; D005260:Female; D006107:Granulosa Cells / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D007265:Inhibins / Q000737:chemistry / Q000378:metabolism*; D008184:Luteal Cells / Q000187:drug effects* / Q000502:physiology*; D010455:Peptides / Q000235:genetics*; D029584:Prostatic Secretory Proteins; D012333:RNA, Messenger / Q000096:biosynthesis* / Q000235:genetics*
D010455:Peptides; D029584:Prostatic Secretory Proteins; D012333:RNA, Messenger; C043076:beta-microseminoprotein; C094377:inhibin-alpha subunit; D007265:Inhibins; D015237:Dinoprost; D015232:Dinoprostone